EdX

Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes (edX)

Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes (edX)

Drugs are biologically active compounds. Drug discovery and drug development rely on methods for measuring biological activity. The term “activity” is quite general. In practice, a substance’s biological activity can refer to how a substance affects a biological pathway, cell-level responses, safety risks, how long a substance resides within in a system, as well as a substance’s effects in an organism (called pharmacodynamics). The design of methods for measuring activity is a critical aspect of drug discovery. The design of robust and informative methods can accelerate the drug discovery and development process.

Class Deals by MOOC List - Click here and see EdX's Active Discounts, Deals, and Promo Codes.

In this course about measuring biological activity, students will learn different methods of activity measurement encountered at different stages of a drug program. The three-week course starts with an introduction to drug targets, which are biological molecules affected by drugs. The second week emphasizes biochemical, cellular, and computational methods for determining the extent to which a drug can affect the action of its target and associated signal pathways. In the final week, students will transition to in vivo studies and the interpretation of dose-response curves.
Students in the course should understand the concepts of proteins and biological pathways. Students should also be comfortable with algebraic expressions, including logarithmic functions. The course is designed in modules. Each module opens with a short video on a selected topic. The module continues with a short reading or exercise with an assessment activity. Each module will require approximately 1 hour to complete, and the course includes 15 modules. Two approaches to the course are recommended. One, a student might spend an hour per day on the course and complete all 15 modules in approximately three weeks. Two, a student with additional available time may be able to work through the entire course in just a single week or over an extended weekend.
Students signed up for the Audit Track have access to the instructional video materials. Students enrolled through the Verified Track have access to the instructional videos, the readings and activities, the assessments, as well as selected additional videos related to the primary instructional videos.

What you'll learn

  • the general idea of target-based drug discovery, in which a drug’s action on a target alters the function of a biological pathway
  • common types of biological molecules that serve as drug targets, especially enzymes and receptors
  • different outcomes of drug-target interactions, including inhibitors, agonists, inverse agonists, and antagonists
  • representative biochemical and cellular methods for measuring drug-target binding
  • types of outcomes used to determine the success of clinical trials
  • the generation and interpretation of dose-response curves

Syllabus

week 1
pathways, targets, and responses
mechanism of action, mode of action, and indication
types of targets and ligands
enzyme and receptor activity curves
potency vs. efficacy

week 2
types of assays
binding assays
in silico assays and screens
functional in vitro assays
comparing potency values

week 3
in vivo preclinical studies
what are biomarkers?
outcomes and surrogate endpoints
dose-response curves
using assays to discover new drugs

Go to Class
MOOC List is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

Related Courses

Drug Commercialization (Coursera) Coursera
University of California, San Diego

Drug Commercialization (Coursera)

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Commercialization course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug commercialization. This course will cover pharmacoeconomic, marketing strategy, intellectual property strategy, portfolio management, managed markets and strategic alliances. It will also have a lecture case study from startup to success.

May 25th 2026
4 Weeks
The Opioid Crisis in America (edX) EdX
HarvardX,Harvard University

The Opioid Crisis in America (edX)

Learn about the opioid epidemic in the United States, including information about treatment and recovery from opioid addiction. On average, 130 Americans die every day from an overdose of opioids, the class of drugs that includes heroin, hydrocodone, codeine, morphine, and fentanyl. Around 70% of all opioid overdose deaths involved a prescription opioid. Drug overdose is now the leading cause of accidental death in the United States — opioid addiction is driving this epidemic.

Self Paced
Self-Paced
Prescription Drug Regulation, Cost, and Access: Current Controversies in Context (edX) EdX
HarvardX,Harvard University

Prescription Drug Regulation, Cost, and Access: Current Controversies in Context (edX)

Understand how the FDA regulates pharmaceuticals and explore debates on prescription drug costs, marketing, and testing. Prescription drugs are among the most common health care interventions and have turnedsome once-fatal diseases into manageable conditions — but they have also been a growing source of controversy.

Self Paced
Self-Paced
Drugs, Peace, and Development: Rethinking Policy (FutureLearn) FutureLearn
SOAS University of London

Drugs, Peace, and Development: Rethinking Policy (FutureLearn)

Gain insights into the relationships between illicit drug economies, peacebuilding, and development in borderland regions. Explore new ways to tackle drugs, development, and peacebuilding challenges. There is growing awareness that the ‘war on drugs’ has failed and that there is a need for reformed drug policies. But what does this mean in practice? On this five-week course from SOAS University of London, you’ll delve into the latest debates in global drug policy and the current efforts to integrate drugs, development, and peacebuilding policies.

Jun 6th 2022
5-12 Weeks
Lead Discovery & Optimization for Efficacy, PK, & Safety (edX) EdX
Davidson College,DavidsonX

Lead Discovery & Optimization for Efficacy, PK, & Safety (edX)

Understanding the efficacy, potency, pharmacokinetics, and safety of compounds is important, but compounds almost always require improvement in their properties in order to become drugs. The process of improvement is called lead optimization and requires a thorough understanding of how a molecule’s structure affects its function, whether efficacy, PK, or toxicity. Unraveling a compound’s structure-function relationship enables lead optimization and hopefully results in the discovery of a compound that can be advanced into clinical trials.

Self Paced
Self-Paced
Introduction to Pharmacokinetics: From ADME to PK/PD (edX) EdX
Davidson College,DavidsonX

Introduction to Pharmacokinetics: From ADME to PK/PD (edX)

A critical aspect of a drug involves how a drug is dosed and circulates throughout the body of a patient. These qualities are aspects of a drug’s pharmacokinetics or PK. Pharmacokinetics encompasses how a drug is absorbed and flows through a patient until it is ultimately eliminated. While pharmacokinetics covers drug behavior in a living organism, PK properties can often be predicted through laboratory tests for a compound’s ADME properties. ADME stands for absorption, distribution, metabolism, and excretion. The PK and ADME properties of potential drug are closely monitored throughout the discovery and early development stages of a drug campaign.

Self Paced
Self-Paced
Case Studies in Personalized Medicine (Coursera) Coursera
Vanderbilt University

Case Studies in Personalized Medicine (Coursera)

Learn how advances in biomedicine hold the potential to revolutionize drug development, drug treatments, and disease prevention: where are we now, and what does the future hold? This course will present short primers in genetics and mechanisms underlying variability in drug responses. A series of case studies will be used to illustrate principles of how genetics are being brought to bear on refining diagnoses and on personalizing treatment in rare and common diseases. The ethical and operational issues around how to implement large scale genomic sequencing in clinical practice will be addressed.

May 25th 2026
5-12 Weeks
Introduction to Small Molecule Drug Discovery & Development (Coursera) Coursera
University of Cape Town

Introduction to Small Molecule Drug Discovery & Development (Coursera)

What does it take to advance a new drug from the laboratory bench to the patient’s bedside? Historically, drugs were discovered serendipitously and were usually isolated from natural sources. Today, drug discovery efforts take many years and cost hundreds of millions of dollars. They also require the input of dozens of specialists from a multitude of backgrounds to ensure that therapeutic molecules are efficacious and safe.

May 25th 2026
4 Weeks
Precision Medicine (Coursera) Coursera
University of Geneva

Precision Medicine (Coursera)

This course will provide you with the key knowledge and tools to understand the fundamentals and practical implications of precision medicine, its opportunities and challenges. It will address precision-medicine era diagnostics, treatment selection, genetic counseling, public health interventions, and biomedical research. It will also deal with data science and ethical issues. From genomic analysis and genetic counseling to cancer biomarkers, from risk assessment of chronic diseases to the understanding of gene-environment interactions, from pharmacogenomics to multi-omics data integration, experts will walk you through the many aspects of precision medicine, from the bench to the bedside and to population health.

Jun 1st 2026
5-12 Weeks